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809-5 Poor Outcome in Subsets of Renal Failure Patients 
Undergoing Coronary Artery Bypass Surgery: Mortality 
Results From a Cohort of 4,069 Patients
Saida Zen Campwala, Ramdas G. Pai, Loma Linda University Medical Center, Loma 
Linda, CA
Background: Renal failure increases mortality in CABG patients. We studied the effect on
mortality of renal failure (creatine>2mg/dl) - both non-dialysis dependent (NDDRF) and
dialysis dependent (DDRF) - in high risk subsets of CABG patients.
Methods: This is a retrospective cohort study of 4069 consecutive adult patients who had
CABG from 1993 to 2002. The mortality data was obtained from the National Death
Index.
Results: The patient characteristics: age 67+12 years, men 73% and LV ejection fraction
(EF) 49+16%. Over 3.9 years, 899 (22%) patients died. There were 3796 patients with
normal renal function, and 273 (7%) with renal failure: 201 (5%) NDDRF and 72 (2%)
DDRF. Patients with renal failure had a 5-year mortality of 56%, compared to 22% in
patients with normal renal function (p<0.0001), with 50% in NDDRF, and 70% in DDRF.
When corrected for the differences in the populations, both NDDRF and DDRF were
independent predictors of mortality. In subset analysis, the 5 year mortalities in NDDRF
and DDRF patients were even higher in patients with LVEF <40% (59 and 74%)}, age
>65 years (60 and 70%) and redo-CABG status (64 and 100%). Besides renal dysfunc-
tion, LV dysfunction, advanced age and redo-CABG status were independent predictors
of mortality.
Conclusions: 1) CABG patients with renal failure have a >50% mortality at 5-years,
being higher in DDRF patients 2) In renal failure patients, LV dysfunction, advanced age,
and redo-CABG status increase the 5 year mortality to prohibitive levels.
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1078-89 Stem Cell Mobilization With Granulocyte Macrophage-
Colony Stimulating Factor Has No Effect on Infarct Size 
and Left Ventricular Function in an Experimental Model 
of Acute Myocardial Infarction
John Terrovitis, Apostolos Papalois, Christos Charitos, Paraskevi Dolou, Aggeliki 
Eleftheriou, Efstratios Charitos, Michail Mponios, Panagiotis Glentis, John Nanas, 
University of Athens School of Medicine, Athens, Greece
Background: Stem-cell therapy appears a promising treatment for cardiac repair in
experimental and small-scale clinical studies in the setting of acute myocardial infarction
(AMI). However, bone-marrow aspiration and in-vitro expansion of the desired cell lines
are time-consuming techniques, impractical for implementation during an acute event. e
sought to evaluate the effect of bone-marrow pluripotent stem-cell mobilization with GM-
CSF on infarct size and left ventricular function in AMI, with a protocol easily applicable in
everyday clinical practice. Methods. Ten pigs weighing 30 ± 5 kg were subjected to left
thoracotomy and occlusion of the left anterior descending coronary artery for 1 hour, fol-
lowed by reperfusion. At 50 minutes of ischemia, the animals were randomized to pla-
cebo (Group A, n=5) or GM-CSF (Group B, n=5). Subsequently, the thoracotomy was
closed and the animals recovered. In Group B, 20 µg/kg GM-CSF (molgrastim) was
administered subcutaneously, daily, for 15 days. All animals underwent echocardio-
graphic evaluation at 5 and 28 days after AMI. At 30 days, they underwent a new thorac-
otomy and determination of the infarct size as a percentage of the whole left ventricular
area (with the use of tetrazolium chloride). Results. No difference was observed
between the two Groups in infarct size (7.8 ± 6.1 % vs 7.5 ± 7.7 %, p= 0.951, for Groups
A and B, respectively). There was also no difference in shortening fraction (short axis
view at the mid-papillary level, 34 ± 0.6 % vs 35 ± 0.5 %, p= 0.907), left ventricular end
diastolic diameter (32 ± 0.2 mm vs 34 ± 0.3 mm, p= 0.361), left ventricular end systolic
diameter (21 ± 0.2 % vs 22 ± 0.4 mm, p= 0.584) and systolic thickness of the infarcted
left ventricular wall (0.97 ± 0.2 mm vs 0.98 ± 0.2 mm, p= 0.972), in Groups A and B,
respectively at 28 days of follow-up. Conclusion. Subcutaneous administration of GM-
CSF in the acute phase of acute MI and early post-infarction period does not result in
either a decrease in infarct size or an improvement in LV function. Other protocols for
adequate stem-cell mobilization and concentration in the injured area should be deter-
mined in order to combine efficacy and clinical applicability.
1078-90 Epidermal-Derived Progenitor Cells Engraft the 
Infarcted Myocardium and Express Cardiomyocyte 
Markers
Satyavardhan Pulukurthy, Ryan P. Dunlay, Timothy E. Lindley, Sarah J. Bonner, 
Christopher C. Oberley, Ram V. Sharma, Martine Dunnwald, Robin L. Davisson, 
University of Iowa, Iowa City, IA
Background: Lack of efficient regenerative capacity of the post-infarcted adult heart has
prompted an intensive search for alternative sources of cells capable of repopulating the
injured myocardium.In this study, we tested the hypothesis that skin-derived epidermal
progenitor cells (EPCs) can engraft and express cardiomyocyte markers when trans-
planted into areas of myocardial infarction (MI).
Methods: EPCs were isolated from the epidermis of green fluorescent protein (GFP+)
transgenic C57 mice. Host non-transgenic C57 mice were given MI via open-chest left
anterior descending coronary artery ligation. At the time of MI, GFP+ EPCs or saline
were injected at 2 sites near the infarct zone. Mice were sacrificed at 1, 3 and 6 weeks
and immunofluorescence was performed on heart sections to detect GFP, cardiac, and
epidermal cell markers.
Results: As early as 1 week post-injection, GFP+ cells were engrafted in the infarcted
region of EPC-injected hearts and co-expressed markers for differentiated cardiomyo-
cytes (MHC, α-actinin). Over 6 weeks, GFP+ cells gradually took on morphological fea-
tures of adult myocytes including striated myofibrils (figure below). This was
accompanied by a loss of the epidermal marker keratin 14.
Conclusion: Epidermal-derived progenitor cells engraft the infarcted myocardium to
repopulate lost cardiomyocytes. The abundance, accessibility, and autologous nature of
the skin may provide an exciting new therapeutic strategy for MI.
1078-91 Transdifferentiation of Mesenchymal Stem Cells Into 
Cardiomyocytes by Direct Cell-to-Cell Contact With 
Nenatal Cardiomyocytes but Not Adult Cardiomyocytes
Jihyun Yoon, Seung-Cheol Choi, Do-Sun Lim, Korea University Medical College, Seoul, 
South Korea
Background: Recent studies have demonstrated that direct cell-to-cell interaction is one
of microenvironment factors for transdifferentiation of adult stem cells into cardiomyo-
cytes. We investigated whether transdifferentiation of MSCs into cardiomyocytes was
dependent on developmental stages of cardiomyocytes cocultured, and direct cell-to-cell
interaction was essential for transdifferentiation. Methods and Results: MSCs were iso-
lated from adult rat and cocultured in four different ways; 1) with neonatal cardiomyo-
cytes, 2) with adult cardiomyocytes, 3) with neonatal cardiomyocytes on the cell culture
inserts (double chamber system), 4) with the conditioned medium from neonatal cardi-
omyocytes. After 5 days of coculture with neonatal cardiomyocytes, 9.40±1.15% of Dil-
labeled MSCs expressed sarcomeric-α-actinin as measured by flow cytometry. Immuno-
cytochemistry showed that only these MSCs expressed the cardiac markers. MSCs
transdifferentiation was not observed with other coculture condition as well as condi-
tioned medium. Calcein-AM labeling of cardiomyocytes showed gap junctional communi-
cation between 56.1 ± 2.0 % of MSCs (24 hours after labeling, n=5) and neonatal
cardiomyocytes. When MSCs cocultured with paraformaldehyde-fixed neonatal cardi-
omyocytes, they also expressed sarcomeric-α-actinin. EDTA abolished the adhesion of
MSCs to fixed neonatal cardiomyocytes. Conclusions: These findings suggest that
MSCs are capable of differentiating into cardiomyocytes when directly cocultured with
neonatal cardiomyocytes by cell-to-cell interaction, but not with adult cardiomyocytes or
with conditioned medium. This finding provides the model to study the mechanism to dif-
ferentiate MSCs into cardiomyocytes by microenvrionment.
1078-92 Human Umbilical Cord Mononuclear Cells Limit Acute 
Myocardial Infarction Size
Robert J. Henning, Hamdi Abu-Ali, John Randolph, Michael Morgan, John Balis, Alison 
Willing, Paul Sanberg, University of South Florida, Tampa, FL, James A. Haley VA 
Hospital, Tampa, FL
Background: We hypothesized that Human Umbilical Cord mononuclear Blood Cells
(HUCBC) can limit acute myocardial infarction size and improve cardiac function.
Methods: Infarction was produced in rats by either left anterior descending coronary
artery permanent occlusion (n=35) or occlusion for one hour then reperfusion (n=36).
Rats from each study were combined because of similar findings. Group 1 consisted of
24 control rats with no intervention. In Group 2 (n=33) the hearts were infarcted but no
HUCBC injected. In Group 3 (n=38) one million HUCBC were injected at the ischemic
zone edges 1 hour after coronary ligation. Immunosuppression was not given to any rat.
Echocardiography was performed at baseline and at 1, 2, 3 and 4 months of observation.
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dP/dtmax was recorded during Left Ventricular (LV) catheterization prior to and during
Phenylephrine (PE) [5-50 micrograms/minute]. Infarct size was measured by tetrazolium
and planimetry.
Results: Mean LV Ejection Fraction (EF) in the short axis in Group 1 was 88 + 3% at
baseline and decreased to 78 + 4% at 4 months (p=0.03). In Group 2, EF decreased
from baseline of 87 + 4% to 51 + 3% at 1 month (p=0.001) and did not change thereafter.
Although EF in Group 3 decreased from 87 + 4 % to 63 + 3% at 1 month, EF progres-
sively increased to 69+6% at 4 months, which was similar to controls but different than
Group 2 (p=0.02). Septal wall thickening in Group 3 was 57.9 + 11.6% at 4 months, which
was nearly identical to the control septal thickening of 59.2 + 8.9 %, and was significantly
greater than Group 2 septal thickening which was only 27.8 + 7% (p=0.02). dP/dtmax in
Group 3 increased from 3568 + 701 to 10062 + 784 mmHg/s (p=0.001) with PE 50 micro-
grams/minute which was similar to maximum control, but only increased from 3955 + 803
to a maximum value of 7534 + 941 mmHg/s in Group 2. The infarct sizes averaged
2.98% + 2.8% for Group 3 versus 22.1% + 5.6 % for Group 2 at three months (p=0.02)
and 9.2 % + 2.0 for Group 3 versus 40.0 + 9.2 for Group 2 (p=0.001) at four months. The
HUCBC migrated from the periphery into the infarction and were aligned and in register
with the host cardiomyocytes at 3 and 4 months.
Conclusion: HUCBC can significantly limit ischemic damage and improve LV function in
the infarcted rat heart.
1078-93 Enhanced Angiogenesis With Autologous Bone Marrow 
Transplantation in a Porcine Nonreperfused Myocardial 
Infarction Model
Ron Waksman, Jana A. Fournadjiev, Richard Baffour, Laurent Leborgne, Rajbabu 
Pakala, David Hellinga, Hamid Yazdi, Edouard Cheneau, Roswitha Wolfram, Rufus 
Seabron, Keneth Horton, Frank Kolodgie, Renu Virmani, Elias Rivera, Washington 
Hospital Center, Washington, DC, Armed Forces Institute of Pathology, Washington, DC
Background: Cell transplantation is becoming a viable strategy to improve revasculariza-
tion and left ventricular function after myocardial infarction (MI) injury. This study evalu-
ated the effect of trans-epicardial bone marrow (BM) cell transplantation on infarct size,
blood vessel formation and myocardial function in a porcine model of non-reperfused MI.
Methods: Coil implants were positioned in the coronary circulation of 13 domestic swine
to produce MI. Twenty-eight days later, autologous BM was aspirated, labeled with bro-
mdeoxyuridine (BrdU), and cultured for 48 hours. Animals underwent a left thoracotomy
and 0.2 ml of BM (~ 1.5 million cells/ml) were injected at 8 sites (1 cm apart) within the
infarcted and border regions of 8 swine; 5 animals injected with saline served as controls.
Animals received systemic BrdU 24 hours prior to euthanasia at 28 days. Regional con-
tractility was assessed by trans-epicardial echography performed at the time of BM injec-
tions and at the end of the study period.
Results: The infarct size (mm2 ) was smaller in the BM transplanted group (81.83±10.65)
than in the control group (147.72±23.25, p= 0.015). BrdU positive cells of BM treated and
controls were 51.66% and 29.19%, respectively. Further, α-actin positive cells were sig-
nificantly greater in the BM injected animals (BM= 314.8±37.4 vs. saline= 167.1±11.9/
0.1mm2, p=0.02) as well as the number of factor VIII positive endothelial cells (BM=
363.3±28.2 vs. saline= 254.4±28.1 cells/0.1mm2, p=0.03). The number of blood vessels
>50µm was significantly increased in the BM group=317.9± 54.9 vs 149.12±
6.08(p<0.05). Wall motion score index was similar in the BM injected and saline groups
at baseline (1.63±0.16 vs. 1.25±0.25, p=0.21) and at 28 days (1.83±0.22 vs. 1.63±0.38,
respectively, p=0.62).
Conclusion: BM cell engraftment of infarcted tissue is feasible with cell viability main-
tained up to 28 days and is an effective strategy for infarct size reduction. Increased
angiogenesis by BM transplantation in a model of non-reperfused MI was not sufficient to
support an improvement in left ventricular function.
1078-94 Acute Myocardial Infarction Is a Stimulus for Stem Cell 
Mobilisation and Elevated Erythropoietin Serum Levels
Korff Krause, K. Jaquet, K. Kyriazis, B. Fehse, C. Lange, A. Zander, K. H. Kuck, St. Georg 
Hospital, Hamburg, Germany, University of Hamburg, Hamburg, Germany
Introduction: Bone marrow derived stem cells have the capacity to home infarcted heart
tissue, and promote cardiac repair as shown in experimental data in animal models. So
we addressed the question wether progenitor cells that have been shown to differentiate
into endothelial cells and cardiomyocytes in vitro and in vivo are mobilized in peripheral
blood (PB) in patients with coronary heart disease (CHD) and determined growth factor
serum levels.
Methods: PB was taken from 16 pts. with acute myocardial infarction (AMI), 8 pts. with
angina pectoris (AP) an 10 pts. without CHD who underwent cornary angiogram (control)
and analysed with FACS analysis (percent/1 million cells). Growth factor and Epo serum
levels were determined with ELISA technique (mU/ml). Samples were drawn at time point
(TP) 1 (day 1-3 after ischemic event) and time point (TP) 2 (day 4-8).
Results: The mean values of CD34+, CD117+ and CD133+ cells were all elevated in pts.
with either AMI or AP compared to the control group. Pts. with AMI had doubled cell
counts of CD117+ and CD34+ progenitor cells in PB compared to pts. with AP. Epo was
significantly elevated in pts. with AP and AMI: 
Conclusion: Pts. with AMI have increased CD34+, CD117+ and CD133+ precursor cell
mobilisation after ischemic events. Acute myocardial infarction is a stimulus for CD117+
and CD34+ progenitor cell mobilisation and Epo may play a role in its regulation.
1078-95 Intracellular Calcium Regulates Tumor Necrosis Factor-
Alpha-Induced Embryonic Stem Cell Migration
Emel Kaplan, Yu Chen, Jiang-Yong Min, Jamal S. Rana, Qinen Ke, James P. Morgan, 
Beth Israel Deaconess Medical Center, Boston, MA
Background: Previously we have shown that after systemic injection of murine embryonic
stem cells (ESCs), these cells home to the hearts of mice suffering from myocarditis. The
purpose of this study was to visualize the migratory pattern of ESCs during TNF-alpha
induced chemotaxis and to test the association between intracellular calcium concentra-
tion ([Ca2+]i) and ESC motility.
Methods: We used high speed optical sectioning microscopy to observe and record the
behavior of ESCs. A direct viewing chemotaxis chamber with two concentric wells (Dunn
chamber) allowed us to establish a linear concentration gradient of TNF-alpha. ESCs
were suspended in a physiological buffer and maintained at 37 °C. Cell movement was
monitored every two minutes over a three hour period, using concentrations of TNF-
alpha of 2.0-10.0 ng/l (n=45). Changes in [Ca2+]i were measured with the fluorescent
dye fura-2/AM.
Results: At these concentrations of TNF-alpha we found that ESCs migrated towards
TNF-alpha in a dose-related manner with mean rates of 1.3-3.6 µm/min. The total move-
ment of the ESCs also varied with different concentrations of TNF-alpha. Furthermore,
TNF-alpha induced the formation of proteopodia, which in turn play an important role in
migration and homing of stem cells.
During migration ESCs showed an increase in intracellular Ca2+. To further investigate
the role of Ca2+ in the migration of ESCs, we monitored cells in the presence and
absence of extracellular Ca2+ and found that presence of extracellular Ca2+ had a posi-
tive effect on migration (n=20).
Conclusion: These results demonstrate that ESCs are highly motile and respond to differ-
ent concentrations of TNF-alpha in a dose-related manner. Also, an increased [Ca2+]i
has a positive effect on such a migration of ESCs. These mechanisms may play a critical
role in heart-specific homing of ESCs, after systemic injection.
1078-96 The Role of Collateral Circulation in the Acute Phase of 
ST-Segment Elevation Myocardial Infarction Treated 
With Primary Coronary Intervention
Peter Elsman, Arnoud W. J. van t' Hof, Kor Miedema, Stoffer Reiffers, Felix Zijlstra, Isala 
Klinieken, location Weezenlanden, Zwolle, The Netherlands
Background: The role of collateral flow in the first hours of infarction remains unclear.
Our aim was to determine whether angiographic evidence of coronary collateral flow has
a beneficial effect on infarct size and left ventricular function in acute myocardial infarc-
tion (MI) treated with early primary coronary intervention (PCI).
Methods: Between 1994 and 2001 1074 patients with acute MI treated with early PCI,
TIMI 0 or 1 flow at first contrast injection and technical adequate angiograms for collateral
flow detection were analysed.
Results: Comparing collateral flow grade 0, 1 and 2/3, increased collateral flow is associ-
ated with lower incidence of Killip class > 2 at presentation (12.% versus 9.8% versus
4%, p for trend 0.01), decreased use of intra aortic balloon pumping (IABP) post-PCI
(17.2% versus 12.8% versus 4.7%, p for trend 0.0005), better myocardial blush grade
(MBG)(MBG3: 21.2% versus 25.4% versus 29.2%, p for trend 0.04) and smaller enzy-
matic infarct size (LDHQ36) (1947±1553 U/l and 1893±1549 U/l versus 1221±767 U/l,
p=0.001). These beneficial effects are particular present in LAD related infarcts.
Conclusion: Presence of angiographically detectable collaterals have a protective effect
on enzymatic infarct size and pre- and post-intervention hemodynamic conditions in
patients with acute MI treated with early PCI, in particular when Rentrop grade 2/3 is
present and in LAD related infarcts.
1078-97 The Protective Effect of Edaravone on Myocardial 
Damage During Ischemia-Reperfusion in Rabbit Heart
Yujirou Tanabe, Shinji Okubo, Yachiyo Hoshiba, Kenji Takeda, Sumiyo Kudoh, Michihiko 
Kitayama, Seiyu Kanemitsu, Hiroichi Tsugawa, Noboru Takekoshi, Kanazawa Medical 
University, Uchinada, Japan
[Background]A free radical scavenger, edaravone has the ability to stimulate prostacy-
cline release and to inhibit the lipoxygenase pathway in the arachidonic acid cascade.
We demonstrated whether edaravone attenuates the myocardial damage in the
ischemia-reperfusion rabbit heart.
[Methods]All rabbits underwent sustained coronary artery occlusion(CAO) for 30 min fol-
lowed by 180 min of reperfusion. 1)Control(n=8), 2)Edaravone-early(n=8, 3mg/kg i.v):10
min before reperfusion, 3) Edaravone-immediately(n=8, 3mg/kg i.v):immediately after
reperfusion, and Edaravone-late(n=8, 3mg/kg i.v):5 min after reperfusion were studied.
Infarct size was determined by TTC staining. The percentage of apoptosis cells (nuclear
DNA fragmentation detection via fluorescence microscopy) was calculated and DNA lad-
der assay was prepared from the ischemic region.
[Results] 1)Infarct size as a percent of the area at risk in control was 42.8±5.2%. Edara-
vone-early (23.5±3.3%) and Edaravone-immediately (24.5±5.3%) were significantly
reduced infarct size (p<0.01) compared with control group. However, when edaravone
was present 5 min after reperfusion, protection was completely abolished (39.6±4.5%).
2) The findings of DNA fragmentation were significantly(p<0.01) decreased in Edara-
vone-early (2.5±1.8%) and Edaravone-immediately (3.2±1.8%) group compared with
control (15±3.9%) and Edaravone-late (13.5±3.3% ).DNA laddering were attenuated in
Edaravone-early and Edaravone-immediately group. [Conclusions] Single bolus adminis-
Time point 1 (mean) Time point 2 (mean)
CD34: AMI/AP/control (%) 0.21/0.19/0.10 0.31/0.27/0.12
CD117: AMI/AP/control (%) 0.09/0.05/0.06 0.30/0.05/0.06
CD133: AMI/AP/control (%) 0.20/0.21/0.11 0.19/0.11/0.10
Epo: AMI/AP/control, (mU/ml) 34.0/24.0/9.0 30.0/27.5/8.2
